Tor Svensjo

  • Citations Per Year
Learn More
BACKGROUND We recently developed a new tetracycline-inducible gene switch employing the tetracycline operator-containing hCMV major immediate-early promoter and the tetracycline repressor, tetR, rather than the previously used tetR-mammalian cell transcription factor fusion derivatives. MATERIALS AND METHODS The present study demonstrates that this(More)
  • 1